Takeda Cambridge Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Takeda Cambridge Ltd (TCB), formerly Paradigm Therapeutics Limited, a subsidiary of Takeda Pharmaceutical Company Ltd, pharmaceutical company that develops novel compounds addressing in various therapeutics areas. The company specializes in chronic pain and urology indications, nervous system disorders, endocrinology and metabolic-related diseases. Its offers ethical drugs and consumer healthcare products. TCBs services include chronic pain and urology indications, CNS disorders, endocrinology and metabolic-related diseases. The company develops products by utilizing genetic models and in vivo pharmacology. It also cultivates and exhibits valuable original plants used in medicines. TCB is headquartered in Cambridge, the UK.

Takeda Cambridge Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Takeda Enters into R&D Agreement with University College London 10
Dimerix Enters Into Second Research Agreement With Takeda Cambridge 11
Evotec Enters Into Collaboration With Takeda Cambridge 11
Takeda Cambridge Ltd - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Cambridge Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Cambridge Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Enters into R&D Agreement with University College London 10
Dimerix Enters Into Second Research Agreement With Takeda Cambridge 11
Evotec Enters Into Collaboration With Takeda Cambridge 11
Takeda Cambridge Ltd, Key Competitors 13
Takeda Cambridge Ltd, Key Employees 14

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

Gastrointestinal Drugs Global Market Forecast To 2022 Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals Covering: Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson

The gastrointestinal drugs market consists of sales of gastrointestinal drugs and related services by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases. This industry

USD 4000 View Report

Takeda Pharmaceutical Company Ltd (4502) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Takeda Pharmaceutical Company Ltd (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available